ABT Abbott Laboratories

USD 113.48 1.98 1.775785
Icon

Abbott Laboratories (ABT) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | NYE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 113.48

+1.98 (+1.78)%

USD 193.47B

7.51M

USD 120.07(+5.80%)

USD 118.47 (+4.40%)

Icon

ABT

Abbott Laboratories (USD)
COMMON STOCK | NYE
USD 113.48
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 193.47B

USD 118.47 (+4.40%)

USD 113.48

Abbott Laboratories (ABT) Stock Forecast

Show ratings and price targets of :
USD 120.07
(+5.80%)

Based on the Abbott Laboratories stock forecast from 9 analysts, the average analyst target price for Abbott Laboratories is USD 120.07 over the next 12 months. Abbott Laboratories’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Abbott Laboratories is Bullish , which is based on 10 positive signals and 4 negative signals. At the last closing, Abbott Laboratories’s stock price was USD 113.48. Abbott Laboratories’s stock price has changed by +1.78% over the past week, -4.96% over the past month and +15.25% over the last year.

No recent analyst target price found for Abbott Laboratories
No recent average analyst rating found for Abbott Laboratories

Company Overview Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provide...Read More

https://www.abbott.com

100 Abbott Park Road, North Chicago, IL, United States, 60064-6400

114,000

December

USD

United States

Adjusted Closing Price for Abbott Laboratories (ABT)

Loading...

Unadjusted Closing Price for Abbott Laboratories (ABT)

Loading...

Share Trading Volume for Abbott Laboratories Shares

Loading...

Compare Performance of Abbott Laboratories Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ABT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Abbott Laboratories (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SYK
Stryker Corporation +8.33 (+2.38%) USD134.32B 42.71 29.24

ETFs Containing ABT

Symbol Name ABT's Weight Expense Ratio Price(Change) Market Cap
UMDV:SW
iShares US Medical Device.. 17.51 % 0.25 % +0.07 (+1.22%) USD0.18B

Frequently Asked Questions About Abbott Laboratories (ABT) Stock

Based on ratings from 9 analysts Abbott Laboratories's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 10 buy, sell and 2 hold ratings.

ABT stock's dividend yield is 1.97%. Our analysis grades ABT stock's dividend yield at D. This means that ABT stock's dividend yield is above 63% of the stocks in the Medical Devices sector in the NYE exchange. Based on this ABT may be a average dividend stock for its sector.

Based on targets from 9 analysts, the average taret price for ABT is USD 120.07 over the next 12 months. The maximum analyst target price is USD 130 while the minimum anlayst target price is USD 107.

ABT stock's Price/Earning ratio is 34.20. Our analysis grades ABT stock's Price / Earning ratio at B. This means that ABT stock's Price/Earning ratio is above 14% of the stocks in the Medical Devices sector in the NYE exchange. Based on this ABT may be undervalued for its sector.

The last closing price of ABT's stock was USD 113.48.

The most recent market capitalization for ABT is USD 193.47B.

Based on targets from 9 analysts, the average taret price for ABT is projected at USD 120.07 over the next 12 months. This means that ABT's stock price may go up by +5.80% over the next 12 months.

Following are ETFs with the highest allocation to Abbott Laboratories's stock :

UMDV:SW

As per our most recent records Abbott Laboratories has 114,000 Employees.

Abbott Laboratories's registered address is 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400. You can get more information about it from Abbott Laboratories's website at https://www.abbott.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...